Given the prominent antitumor effect and good safety performance of KW-2478 and the importance of HSP90 in maintaining the structure and function of BCR/ABL, we wondered whether KW-2478 would be an ideal therapeutic method for CML patients. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.